P2Y(12) Antagonists in Cardiovascular Disease—Finding the Best Balance Between Preventing Ischemic Events and Causing Bleeding

Dual antiplatelet therapy comprising of aspirin and oral P2Y(12) receptor antagonists are an established cornerstone of therapy in acute coronary syndromes and percutaneous coronary intervention. As a result, the platelet P2Y(12) receptor remains a key therapeutic target in cardiovascular medicine s...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernando, Himawan, McFadyen, James D., Wang, Xiaowei, Shaw, James, Stub, Dion, Peter, Karlheinz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133423/
https://www.ncbi.nlm.nih.gov/pubmed/35647068
http://dx.doi.org/10.3389/fcvm.2022.854813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133423/
https://www.ncbi.nlm.nih.gov/pubmed/35647068
http://dx.doi.org/10.3389/fcvm.2022.854813

Ejemplares similares